[1] Pinzani M. Liver fibrosis. Springer Semin Immunopathol,1999,21:475-490.
[2] Asahina K, Zhou B, Pu WT, et al. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology,2011,53:983-995.
[3] Enzan H, Himeno H, Hiroi M, et al. Development of hepatic sinusoidal structure with special reference to the Ito cells. Microsc Res Tech,1997,39:336-349.
[4] Friedman SL, Roll FJ, Boyles J, et al. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A,1985,82:8681-8685.
[5] Filliol A, Saito Y, Nair A, et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature,2022,610:356-365.
[6] Bosselut N, Housset C, Marcelo P, et al. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts. Proteomics, 2010,10:1017-1028.
[7] Lemoinne S, Cadoret A, Rautou PE, et al. Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles. Hepatology,2015,61:1041-1055.
[8] Lua I, Li Y, Zagory JA, et al. Characterization of hepatic stellate cells, portal fibroblasts, and mesothelial cells in normal and fibrotic livers. J Hepatol,2016,64:1137-1146.
[9] Nishio T, Hu R, Koyama Y, et al. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice. J Hepatol,2019,71:573-585.
[10] Schaffner F, Barka T, Popper H. Hepatic mesenchymal cell reaction in liver disease. Exp Mol Pathol,1963,2:419-441.
[11] Kinnman N, Housset C. Peribiliary myofibroblasts in biliary type liver fibrosis. Front Biosci, 2002,7:d496-503.
[12] Dranoff JA, Wells RG. Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology,2010,51:1438-1444.
[13] Lei L, Bruneau A, El Mourabit H, et al. Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis. Hepatology,2022,76:1360-1375.
[14] Chen W, Teschendorff AE. Estimating Differentiation Potency of Single Cells Using Single-Cell Entropy (SCENT). Methods Mol Biol,2019,1935:125-139.
[15] Fuji H, Miller G, Nishio T, et al. The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis. Front Mol Biosci,2021,8:790032.
[16] Trussoni CE, O’Hara SP, LaRusso NF. Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target. Semin Immunopathol, 2022,44:527-544.
[17] Guicciardi ME, Trussoni CE, LaRusso NF, et al. The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis. Hepatology,2020,71:741-748. |
